SCHEMBL3817537

SCHEMBL3817537

CC[CH]C1CCCCN1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27876252 0.98 SLC6A2 (0.37)
SCHEMBL447293 0.93
SCHEMBL27466565 0.84 SLC6A2 (0.38)
SCHEMBL14032382 0.78 SLC6A2 (0.36)
SCHEMBL2090139 0.78 SLC6A2 (0.41)
SCHEMBL1515328 0.73
SCHEMBL27087454 0.71
SCHEMBL13560137 0.71
SCHEMBL25842227 0.71
SCHEMBL20537294 0.71 SLC6A2 (0.36)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2016181312-A1 POLYCYCLIC EPOXIDES AND COMPOSITIONS THEREOF WITH ANTI-CANCER ACTIVITIES VERSITECH LIMITED (CN) 2016-11-17 WO disclosed
EP-2091948-A1 NOVEL INHIBITORS OF GLUTAMINYL CYCLASE Probiodrug AG (DE) 2009-08-26 EP disclosed
WO-2008065141-A1 NOVEL INHIBITORS OF GLUTAMINYL CYCLASE PROBIODRUG AG (DE) 2008-06-05 WO disclosed